FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Börse Stuttgart 08:09:27 2024-07-17 am EDT | ||
| 14.33 EUR | +10.06% |
|
| Current month | +40.91% | ||
| 1 month | +24.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 14.33 | +10.06% |
| 24-07-16 | 13.02 | +2.36% |
| 24-07-15 | 12.72 | -0.70% |
| 24-07-12 | 12.81 | +19.05% |
| 24-07-11 | 10.76 | -2.27% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 08:09 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3DH1 |
| ISIN | DE000MG3DH10 |
| Date issued | 2024-04-30 |
| Strike | 123.9 $ |
| Maturity | Unlimited |
| Parity | 1.52 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.83 € |
|---|---|
| Lowest since issue | 9.24 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
148.6
USD
Average target price
150.4
USD
Spread / Average Target
+1.23%
- Stock Market
- Certificates
- Certificat
